UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 10, 2023
Accession Number:
0001193125-23-137754
Submission Type:
POS AM
CIK:
0001835022
Company Name:
Coya Therapeutics, Inc.
File Number:
333-268482